Irinotecan monotherapy as third- or further-line treatment for patients with small cell lung cancer

Zenta Seto, Naoki Takata, Nozomu Murayama, Kotaro Tokui, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Minehiko Inomata*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Irinotecan monotherapy as third- or further-line treatment for patients with small cell lung cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science